National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

panitumumabPatient Information
A human monoclonal antibody produced in transgenic mice that attaches to the transmembrane epidermal growth factor (EGF) receptor. Panitumumab may inhibit autocrine EGF stimulation of tumor cells that express the EGF receptor, thereby inhibiting tumor cell proliferation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:clone E7.6.3
monoclonal antibody ABX-EGF
US brand name:Vectibix
Abbreviation:MOAB ABX-EGF
Code name:ABX-EGF



Previous:pamidronate disodium, pan HER/VEGFR2 receptor tyrosine kinase inhibitor BMS-690154, pan-AKT kinase inhibitor GSK690693, Panglobulin, Panhematin
Next:panobinostat, Panretin, PANVAC-F, PANVAC-V, Panwarfin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov